Exact Mass: 306.1593

Exact Mass Matches: 306.1593

Found 9 metabolites which its exact mass value is equals to given mass value 306.1593, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

(R)-Ruxolitinib

3-cyclopentyl-3-(4-{1H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)propanenitrile

C17H18N6 (306.1593)


   

methyl 2-chloro-2-carboxy-6,10-dimethylundecanoate

methyl 2-chloro-2-carboxy-6,10-dimethylundecanoate

C15H27ClO4 (306.1598)


   

Ruxolitinib (INCB018424)

Ruxolitinib (INCB018424)

C17H18N6 (306.1593)


   

Chlorosphaerolactylate B

2-(12-chloro-dodecanoyloxy)-propanoic acid

C15H27O4Cl (306.1598)


   

Chlorosphaerolactylate C

2-(6-chloro-dodecanoyloxy)-propanoic acid

C15H27O4Cl (306.1598)


   

Ruxolitinib

Ruxolitinib

C17H18N6 (306.1593)


D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AH - Agents for dermatitis, excluding corticosteroids L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EJ - Janus-associated kinase (jak) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

S-Ruxolitinib

S-Ruxolitinib

C17H18N6 (306.1593)


   

Deuruxolitinib

Deuruxolitinib

C17H18N6 (306.1593)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor

   

3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]propanenitrile

3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]propanenitrile

C17H18N6 (306.1593)